Biosensors consists of abiological recognition unit, which has the ability to interact withbioelements, such as living tissue, enzymes, and antibodies, and a transducer,which is used to change the property of bioelements into an electrical signal.The recordable signal is analyzed for a variety of applications. Biosensors arehighly beneficial devices for measuring a wide spectrum of analytes, such asbacteria, gases, organic compounds and ions, in the fields of food testing,medical diagnosis, and environmental monitoring.
Statistics:
The global BiosensorsMarket is estimated to account for US$ 22,551.2 Mn in terms of value by theend of 2020.
Global Biosensors Market: Drivers
Approval and launch of new productsis expected to propel growth of the global biosensors market over the forecastperiod. For instance, in February 2018, Nanomedical Diagnostics launchedGraphene Biosensor- FLEX, which can be easily integrated with company’s AgileR100 protein assay system to increase the efficiency of the drug discoveryprocess.
Global Biosensors Market:Opportunities
R&D in field-effecttransistors is expected to offer lucrative growth opportunities for players inthe global biosensors market. Field-effect transistor biosensors offer highsensitivity, rapid response, low power operation, label-free workingenvironment, and feasibility for commercialization.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/1647
Global Biosensors Market:Restraints
Reimbursement policy issues inhealthcare systems are expected to hinder growth of the global biosensorsmarket. Reimbursement policies vary widely from country to country. Patientaccess to healthcare usually does vary within a country as well. In developingcountries, such as India and China, the disease burden is high. Majority of thepopulation does not have access to primary healthcare services, attributable topoverty and absence of health insurance. In addition, rising healthcare cost inthese countries and lack of approval of biosensing devices for reimbursementare hampering the affordability of healthcare facilities among the agingpopulation.
Key Takeaways:
The global biosensors market wasvalued at US$ 20,501.1Mn in 2019 and is forecast to reach a value of US$43,073.2 Mn by 2027 at a CAGR of 9.7% between 2020 and 2027. Increasingprevalence of chronic diseases is expected to assist the market growth,
Electrochemical segment helddominant position in the global biosensors market in 2019, accounting for 76.9%share in terms of value, increasing approval and launch of new products isexpected to propel growth of the segment during the forecast period.
Market Trends
Use of AI in biosensors isexpected to propel growth of the global biosensors market. For instance, inMarch 2018, a study backed by the U.S. Dept. of Veterans Affairs reported thatwearable biosensors with artificial intelligence-based analytics can provideaccurate early detection of impending rehospitalization similar to implanteddevices.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/biosensors-market-1647
Moreover, R&D in biosensorsis also expected to propel growth of the global biosensors market. Forinstance, in August 2020, researchers from The University of New Mexico and theAutonomous University of Madrid (UAM) in Spain, reported investigating thelattice resonances supported by bipartite nanoparticle arrays. The researchersconcluded that nanophotonics has the potential to improve light-basedbiosensors.
Global Biosensors Market:Competitive Landscape
Major players operating in theglobal biosensors market include, Nemaura Medical, Inc., MediWise Ltd.,Integrity Applications Inc., OrSense, Medtronic Plc, GE Healthcare, PhilipsHealthcare, Akers Biosciences, Inc., Abbott Laboratories, F. Hoffman-La RocheLtd., Siemens AG, LifeScan, Inc., Acon Laboratories Inc., Universal Biosensors,Nova Biomedical Corp., Bio-Rad Laboratories Inc., Ercon, Inc., Biacore, SysmexCorporation, FreeScale Semiconductors, Omnivision Technologies, Inc., SmithsMedical, Analog Devices, Inc., Honeywell International, Inc., LifeSensors,Inc., Johnson & Johnson, Bayer AG, Smiths Detection, TaiDoc TechnologyCorporation, Efferent Labs, and I-SENS, Inc.
Global Biosensors Market: KeyDevelopments
Major players in the globalbiosensors market are focused on adopting M&A strategies to expand theirproduct portfolio. For instance, in August 2020, Smiths Detection completed theacquisition of PathSensors, a bio-technology solutions andenvironmental-testing company, based in Baltimore, MD, U.S.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/1647
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN: +050-5539-1737
